Cargando…
A new generation of recombinant polypeptides combines multiple protein domains for effective antimicrobial activity
BACKGROUND: Although most of antimicrobial peptides (AMPs), being relatively short, are produced by chemical synthesis, several AMPs have been produced using recombinant technology. However, AMPs could be cytotoxic to the producer cell, and if small they can be easily degraded. The objective of this...
Autores principales: | Roca-Pinilla, Ramon, López-Cano, Adrià, Saubi, Cristina, Garcia-Fruitós, Elena, Arís, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275485/ https://www.ncbi.nlm.nih.gov/pubmed/32503648 http://dx.doi.org/10.1186/s12934-020-01380-7 |
Ejemplares similares
-
Sequence edition of single domains modulates the final immune and antimicrobial potential of a new generation of multidomain recombinant proteins
por: Roca-Pinilla, Ramon, et al.
Publicado: (2021) -
The future of recombinant host defense peptides
por: Roca-Pinilla, Ramon, et al.
Publicado: (2022) -
Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain
por: López-Cano, Adrià, et al.
Publicado: (2022) -
A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins
por: López-Cano, Adrià, et al.
Publicado: (2023) -
Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications
por: Roca-Pinilla, Ramon, et al.
Publicado: (2020)